2025-06-25: Don’t Skip a Beat… Cardiovascular Pharmacotherapy Update - Lake Placid

Dr. Saseem is awesome. His knowledge of lipid lowering drug clinical trials is impressive and inspirational. You can always tell a good conference by the level of engagement between the class and speaker. The questions and discussion are the best I’ve ever experienced. There’s not a question he won’t take the time to answer. The only downfall is that all this learning uses more energy than fuel provided. A snack bar to help make it through that last lecture before lunch would fix that ; )

The course was very well organized. The topics and information was relevant and presented in a way that was easy to understand. The speaker was engaging, knowledgeable, and concise. I also liked the quizzes to help cement what we learned. I will definitely look to attend another program when I can.

This session on lipids was exactly what I needed!!! Thank you - very informative! I also really appreciate the discussion about the development of new drugs in trials and when they are supposed to be approved or not. Not many speakers give that information and it’s so good to know!!

Thank you for a wonderful presentation. Appreciated the in-depth overview on cholesterol, statins and management.
Incredible day of content, thank you so much! Dr. Sanseen is engaging and energetic. His knowledge and the way he delivers the information is exceptional!

Enjoyed the course and appreciated the expertise of the speakers.
Our course speaker relayed information very much on point and tried to answer questions from Zoom participants as well. The challenge in the course was in the problems with the participant questioning survey in which there were technical snafus during the program but that is not the fault of the speaker. It was overall helpful to have questions on survey for participant review of material.
— Session 1 Comments
  • 1. Define what “palliative care” is and state the overall pharmacological goals of palliative care. 2. State common symptoms experienced by palliative care patients with the following diseases: (a) Cancer; (b) COPD; (c) Renal disease; (d) Liver disease; (e) ALS; (f) Parkinson’s disease.

    3. Compare and contrast core pharmacological principles for the use of opioids in palliative care patients versus hospice patients.

    4. Describe best practice for use of common pain medications including agent selection, dosing, titration, routes of administration and common side effects of: Opioids (morphine, methadone, fentanyl, oxycodone, hydrocodone, hydromorphone and buprenorphine) Adjuvants such as NSAIDS, anti-depressants, anticonvulsants.

    5. Propose a pharmacological management strategy for each of the following symptoms: (a) nausea and vomiting (b) dyspnea (c) mental status changes (anxiety, agitation, hallucinations) (d) constipation (e) pruritus (f) insomnia (g) anorexia; cachexia (h) weakness and fatigue (i) muscle spasms.

    6. Cite four general principles for medication optimization (deprescribing) to improve the pharmacological outcomes of palliative care patients.

  • 1. Illustrate the physiological effects of hyperinsulinemia and insulin resistance in the pathogenesis of type 2 diabetes.

    2. Explain the relationship between insulin and the medications used to treat type 2 diabetes in the context of hyperinsulinemia and insulin resistance.

    3. Summarize the evidence for Therapeutic Carbohydrate Restriction (TCR) for people with type 2 diabetes.

    4. Recognize the appropriate management of type 2 diabetes patients with both medication and lifestyle interventions.

    5. Demonstrate the various modes of critical thinking to Type 2 diabetes treatment.

    6. Apply the tools of Evidence Based Medicine to personalize diabetes treatment.

     

About This Course

This on demand course was recorded live in Lake Placid in June 25-26 2025. It provides 15 hours. live AAFP/ AMA PRA Category 1 Credit™, ACPE and pharmacology CE/ CME credit.

Price $299

Watch Day1 Part 1 for free.

Dr. Joseph Saseen, Pharm.D., FASHP, FCCP, BCPS, BCACP

Joseph Saseen is Associate Dean for Clinical Affairs and Professor of Clinical Pharmacy and a Professor of Family Medicine. He also served as Vice Chair of the Department of Clinical Pharmacy for 10 years. Dr. Saseen has responsibilities for enhancing the school’s clinical enterprise, further developing sustainable clinical service models, and advocating for advancing the practice of pharmacy in the State of Colorado. His scholarly work includes almost 200 peer-reviewed publications and book chapters.

More ...

TARGET AUDIENCE/ ACCREDITATION

PHARMACISTS :University Learning Systems is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. These programs are accredited for pharmacists.

NURSE PRACTITIONERS/ NURSES: This course provides 15 contact hours (1.5 CEU) over three days, 5 hours per day, to fulfill the pharmacotherapeutics/ pharmacology requirements for American Nurses Credentialing Center (ANCC) Category 1 Continuing Education Hours  for certification renewal. The same hours submitted to renew certification may be submitted to a State Board of Nursing for re-licensure. American Nurses Credentialing Center (ANCC) accepts formally approved continuing education sponsored by organizations accredited or approved by the Accreditation Council for Pharmacy Education (ACPE). .

PHYSICIANS: The AAFP has reviewed Providing Better Patient Care June 10-12, 2025 and deemed it acceptable for up to 15.00 AAFP Prescribed credit(s). Term of Approval is from 06/10/2025 to 06/12/2028. Physicians should claim only the credit commensurate with the extent of their participation in the activity. AAFP Prescribed credit is accepted by the American Medical Association as equivalent to AMA PRA Category 1 Credit™ toward the AMA Physician’s Recognition Award.  When applying for the AMA PRA, Prescribed credit earned must be reported as Prescribed, not as Category 1. 

CME programs approved by the AAFP are eligible for Category 2 credit  (or Category 1-A  under special circumstances) through the American Osteopathic Association (AOA).

PHYSICIAN ASSISTANTS: American Academy of Physician Assistants (AAPA) accepts certificates of participation for educational activities certified for Prescribed credit from AAFP. Physician assistants may report the number of hours stated above of Category I credit for completing this program.

CONSULTANT PHARMACISTS: Some consultant pharmacist boards accept University Learning Systems courses for recertification either as is or with board approval. Please contact your board regarding course approval and ULS with any questions.

CANADIAN PHARMACISTS: Canadian Council on Continuing Education in Pharmacy (CCCEP) accepts courses accredited by the Accreditation Council for Pharmacy Education (ACPE).  This credit is applicable to health professionals who may require pharmacology credit.

CANADIAN PHYSICIANS: Members of the College of Family Physicians of Canada are eligible to receive up to 15 MAINPRO-M1 credits for participation in this activity due to reciprocal agreement with the American Academy of Family Physicians.

OTHER HEALTH PROFESSIONALS: Contact your respective board regarding approval.